These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 22356480)

  • 41. How do we identify RHD variants using a practical molecular approach?
    Arnoni CP; Latini FR; Muniz JG; Gazito D; Person Rde M; de Paula Vendrame TA; Barreto JA; Castilho L
    Transfusion; 2014 Apr; 54(4):962-9. PubMed ID: 24579654
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Frequency of RHD variants in Brazilian blood donors from Parana State, Southern Brazil.
    Zacarias JM; Pereira EM; Visentainer JE; Guelsin GA; de Melo FC; Sell AM
    Transfus Apher Sci; 2016 Aug; 55(1):120-4. PubMed ID: 27184292
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comprehensive analysis of RHD alleles in Argentineans with variant D phenotypes.
    Brajovich ME; Boggione CT; Biondi CS; Racca AL; Tarragó M; Nogués N; Muñiz-Díaz E; Cotorruelo CM
    Transfusion; 2012 Feb; 52(2):389-96. PubMed ID: 21883261
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular basis of weak D and DEL in Han population in Anhui Province, China.
    Chen Q; Li M; Li M; Lu XS; Lü R; Sun J; Liu Z
    Chin Med J (Engl); 2012 Sep; 125(18):3251-5. PubMed ID: 22964318
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effective molecular RHD typing strategy for blood donations.
    Polin H; Danzer M; Hofer K; Gassner W; Gabriel C
    Transfusion; 2007 Aug; 47(8):1350-5. PubMed ID: 17655577
    [TBL] [Abstract][Full Text] [Related]  

  • 46. How I manage donors and patients with a weak D phenotype.
    Flegel WA
    Curr Opin Hematol; 2006 Nov; 13(6):476-83. PubMed ID: 17053462
    [TBL] [Abstract][Full Text] [Related]  

  • 47. D category IV: a group of clinically relevant and phylogenetically diverse partial D.
    von Zabern I; Wagner FF; Moulds JM; Moulds JJ; Flegel WA
    Transfusion; 2013 Nov; 53(11 Suppl 2):2960-73. PubMed ID: 23461862
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular characterisation of RhD variants in North Indian blood donor population.
    Khetan D; Verma A; Chaudhary RK; Shukla JS
    Transfus Med; 2020 Aug; 30(4):295-303. PubMed ID: 32488899
    [TBL] [Abstract][Full Text] [Related]  

  • 49. RHD allelic identification among D-Brazilian blood donors as a routine test using pools of DNA.
    Mota M; Dezan M; Valgueiro MC; Sakashita AM; Kutner JM; Castilho L
    J Clin Lab Anal; 2012 Feb; 26(2):104-8. PubMed ID: 22467325
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The RHD(1227G>A) DEL-associated allele is the most prevalent DEL allele in Australian D- blood donors with C+ and/or E+ phenotypes.
    Scott SA; Nagl L; Tilley L; Liew YW; Condon J; Flower R; Hyland CA
    Transfusion; 2014 Nov; 54(11):2931-40. PubMed ID: 24894016
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Overview of the serologic and molecular basis of D variants with a focus on D variants in the Indian population.
    Parchure DS; Mishra GV; Kulkarni SS
    Immunohematology; 2023 Apr; 39(1):19-31. PubMed ID: 37017595
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Identification strategy of RHCE gene variants at the National Blood Group Reference Laboratory: impact on transfusion safety].
    Ansart-Pirenne H
    Transfus Clin Biol; 2006; 13(1-2):13-8. PubMed ID: 16563835
    [TBL] [Abstract][Full Text] [Related]  

  • 53. How do I manage Rh typing in obstetric patients?
    Haspel RL; Westhoff CM
    Transfusion; 2015 Mar; 55(3):470-4. PubMed ID: 25647404
    [No Abstract]   [Full Text] [Related]  

  • 54. Transfusion strategy for weak D Type 4.0 based on RHD alleles and RH haplotypes in Tunisia.
    Ouchari M; Srivastava K; Romdhane H; Jemni Yacoub S; Flegel WA
    Transfusion; 2018 Feb; 58(2):306-312. PubMed ID: 29193104
    [TBL] [Abstract][Full Text] [Related]  

  • 55. RHD genotyping and its implication in transfusion practice.
    Sassi A; Ouchari M; Houissa B; Romdhane H; Abdelkefi S; Chakroun T; Jemni Yacoub S
    Transfus Apher Sci; 2014 Dec; 51(3):59-63. PubMed ID: 25457010
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Screening for DEL phenotype in RhD negative Indians.
    Kulkarni S; Parchure DS; Gopalkrishnan V; Madkaikar M
    J Clin Lab Anal; 2018 Mar; 32(3):. PubMed ID: 28643361
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Standardization of a multiplex assay to identify weak D types in a mixed-race Brazilian population.
    Silva TCS; Dezan MR; Cruz BR; Costa SSM; Dinardo CL; Bordin JO
    Immunohematology; 2023 Sep; 39(3):93-100. PubMed ID: 37843969
    [No Abstract]   [Full Text] [Related]  

  • 58. DNB: a partial D with anti-D frequent in Central Europe.
    Wagner FF; Eicher NI; Jørgensen JR; Lonicer CB; Flegel WA
    Blood; 2002 Sep; 100(6):2253-6. PubMed ID: 12200394
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identifying obstetrics patients in whom RHD genotyping can be used to assess risk of D alloimmunization.
    Horn TN; Keller J; Keller MA; Klinger L
    Immunohematology; 2020 Dec; 36(4):146-151. PubMed ID: 33544620
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular analysis of patients with weak D and serologic analysis of those with anti-D (excluding type 1 and type 2).
    Pham BN; Roussel M; Gien D; Ripaux M; Carine C; Le Pennec PY; Andre-Botte C
    Immunohematology; 2013; 29(2):55-62. PubMed ID: 24094237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.